Uncontrolled Zinc- and Copper-Induced Oligomerisation of the Human Complement Regulator Factor H and Its Possible Implications for Function and Disease

Journal of Molecular Biology

Volumn 384, Issue 5, 2008, Pages 1341-1352

  Nan, Ruodan ^a   Gor, Jayesh ^a   Lengyel, Imre ^b   Perkins, Stephen J ^a  

^a UNIVERSITY COLLEGE LONDON   (United Kingdom)

^b UNIVERSITY COLLEGE LONDON   (United Kingdom)

Author keywords

age related macular degeneration; analytical ultracentrifugation; complement factor H; inflammation; X ray scattering

Indexed keywords

CADMIUM; CALCIUM; COMPLEMENT FACTOR H; COPPER; EDETIC ACID; IRON; MAGNESIUM; NICKEL; ZINC;

ARTICLE; CONTROLLED STUDY; DIMERIZATION; HUMAN; OLIGOMERIZATION; OUTCOME ASSESSMENT; PRIORITY JOURNAL; PROTEIN FUNCTION; PROTEIN POLYMORPHISM; RADIATION SCATTERING; RETINA; RETINA MACULA AGE RELATED DEGENERATION; SEDIMENTATION RATE; ULTRACENTRIFUGATION;

EID: 56949096518     PISSN: 00222836     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jmb.2008.10.030     Document Type: Article

References (56)

1. Law S.K.A., and Reid K.B.M. Complement (Second Edition) (1995), IRL Press, Oxford, UK
2. Whaley K., and Ruddy S. Modulation of the alternative complement pathways by beta1H globulin. J. Exp. Med. 144 (1976) 1147-1163
3. Pangburn M.K., Schreiber R.D., and Muller-Eberhard H.J. Human complement C3b inactivator: isolation, characterization, and demonstration of an absolute requirement for the serum protein beta1H for cleavage of C3b and C4b in solution. J. Exp. Med. 146 (1977) 257-270
4. Weiler J.M., Daha M.R., Austen K.F., and Fearon D.T. Control of the amplification convertase of complement by the plasma protein beta1H. Proc. Natl Acad. Sci. USA 73 (1976) 3268-3272
5. Farries T.C., Seya T., Harrison R.A., and Atkinson J.P. Competition for binding sites on C3b by CR1, CR2, MCP, factor B and factor H. Complement Inflammation 7 (1990) 30-41
6. Soares D., and Barlow P.N. Complement control protein modules in the regulators of complement activators. In: Morikis D., and Lambris J.D. (Eds). Structural Biology of the Complement System (2005), Taylor & Francis, Boca Raton, FL 19-62
7. Ormsby R.J., Jokiranta T.S., Duthy T.G., Griggs K.M., Sadlon T.A., Giannakis E., and Gordon D.L. Localization of the third heparin-binding site in the human complement regulator factor H. Mol. Immunol. 43 (2006) 1624-1632
8. Sharma A.K., and Pangburn M.K. Identification of three physically and functionally distinct binding sites for C3b in human complement factor H by deletion mutagenesis. Proc. Natl Acad. Sci. USA 93 (1996) 10996-11001
9. Jokiranta T.S., Hellwage J., Koistinen V., Zipfel P.F., and Meri S. Each of the three binding sites of factor H interacts with a distinct site on C3b. J. Biol. Chem. 275 (2000) 27657-27662
10. Oppermann M., Manuelian T., Jozsi M., Brandt E., Jokiranta T.S., Heinen S., et al. The C-terminus of complement regulator factor H mediates target recognition: evidence for a compact conformation of the native protein. Clin. Exp. Immunol. 144 (2006) 342-352
11. Ferreira V.P., Herbert A.P., Hocking H.G., Barlow P.N., and Pangburn M.K. Critical role of the C-terminal domains of factor H in regulating complement activation at cell surfaces. J. Immunol. 177 (2006) 6308-6316
12. Saunders R.E., Abarrategui-Garrido C., Frémeaux-Bacchi V., Goicoechea de Jorge E., Goodship T.H.J., López Trascasa M., et al. The interactive factor H-atypical haemolytic uraemic syndrome mutation database and website: update and integration of membrane cofactor protein and factor I mutations with structural models. Hum. Mutat. 28 (2007) 222-234
13. Klein R.J., Zeiss C., Chew E.Y., Tsai J.Y., Sackler R.S., Haynes C., et al. Complement factor H polymorphism in age-related macular degeneration. Science 308 (2005) 385-389
14. Haines J.L., Hauser M.A., Schmidt S., Scott W.K., Olson L.M., Gallins P., et al. Complement factor H variant increases the risk of age-related macular degeneration. Science 308 (2005) 419-421
15. Edwards A.O., Ritter III R., Abel K.J., Manning A., Panhuysen C., and Farrer L.A. Complement factor H polymorphism and age-related macular degeneration. Science 308 (2005) 421-424
16. Hageman G.S., Anderson D.H., Johnson L.V., Hancox L.S., Taiber A.J., Hardisty L.I., et al. A common haplotype in the complement regulatory gene factor H (HF1/CFH) predisposes individuals to age-related macular degeneration. Proc. Natl Acad. Sci. USA 102 (2005) 7227-7232
17. Li M., Atmaca-Sonmez P., Othman M., Branham K.E.H., Khanna R., Wade M.S., et al. CFH haplotypes without the Y402H coding variant show strong association with susceptibility to age-related macular degeneration. Nat. Genet. 38 (2006) 1049-1054
18. Maller J., George S., Purcell S., Fagerness J., Altshuler D., Daly M.J., and Seddon J.M. Common variation in three genes, including a noncoding variant in CFH, strongly influences risk of age-related macular degeneration. Nat. Genet. 38 (2006) 1055-1059
19. Hughes A.E., Orr N., Esfandiary H., Diaz-Torres M., Goodship T., and Chakravarthy U. A common CFH haplotype, with deletion of CFHR1 and CFHR3, is associated with lower risk of age-related macular degeneration. Nat. Genet. 38 (2006) 1173-1177
20. Crabb J.W., Miyagi M., Gu X., Shadrach K., West K.A., Sakaguchi H., et al. Drusen proteome analysis: an approach to the etiology of age-related macular degeneration. Proc. Natl Acad. Sci. USA 99 (2002) 14682-14687
21. Hageman G.S., Luthert P.J., Victor Chong N.H., Johnson L.V., Anderson D.H., and Mullins R.F. An integrated hypothesis that considers drusen as biomarkers of immune-mediated processes at the RPE-Bruch's membrane interface in aging and age-related macular degeneration. Prog. Retinal Eye Res. 20 (2001) 705-732
22. Bird A.C. Bruch's membrane change with age. Br. J. Ophthalmol. 76 (1992) 166-168
23. Bird A.C., Bressler N.M., Bressler S.B., Chisholm I.H., Coscas G., Davis M.D., et al. An international classification and grading system for age-related maculopathy and age-related macular degeneration. Surv. Ophthalmol. 39 (1995) 367-374
24. Galin M.A., Nano H.D., and Hall T. Ocular zinc concentration. Invest. Ophthalmol. 1 (1962) 142-148
25. Lengyel I., Flinn J.M., Peto T., Linkous D.H., Cano K., Bird A.C., et al. High concentration of zinc in sub-retinal pigment epithelial deposits. Exp. Eye Res. 84 (2007) 772-780
26. Crossley L.G., and Porter R.R. Purification of the human complement control protein C3b inactivator. Biochem. J. 191 (1980) 173-182
27. Perkins S.J., Nealis A.S., and Sim R.B. Oligomeric domain structure of human complement factor H by X-ray and neutron solution scattering. Biochemistry 30 (1991) 2847-2857
28. Perkins S.J., Okemefuna A.I., Fernando A.N., Bonner A., Gilbert H.E., and Furtado P.B. X-ray and neutron scattering data and their constrained molecular modelling. Mol. Cell. Biol. 84 (2008) 375-423
29. Cole J.L., Lary J.W., Moody T.P., and Laue T.M. Analytical ultracentrifugation: sedimentation velocity and sedimentation equilibrium. Mol. Cell. Biol. 84 (2008) 143-211
30. Nan R., Gor J., and Perkins S.J. Implications of the progressive self-association of wild-type human factor H for complement regulation and disease. J. Mol. Biol. 375 (2008) 891-900
31. Aslam M., and Perkins S.J. Folded-back solution structure of monomeric factor H of human complement by synchrotron X-ray and neutron scattering, analytical ultracentrifugation and constrained molecular modelling. J. Mol. Biol. 309 (2001) 1117-1138
32. 2+ ion on the degradation of the complement activation fragment C3b. Biochem. Soc. Trans. 14 (1986) 73-74
33. Blom A.M., Kask L., Ramesh B., and Hillarp A. Effects of zinc on factor I cofactor activity of C4b-binding protein and factor H. Arch. Biochem. Biophys. 418 (2003) 108-118
34. Tsiftsoglou S.A., and Sim R.B. Human complement factor I does not require cofactors for cleavage of synthetic substrates. J. Immunol. 173 (2004) 367-375
35. An E., Lu X., Flippin J., Devaney J.M., Halligan B., Hoffman E.P., et al. Secreted proteome profiling in human RPE cell cultures derived from donors with age related macular degeneration and age matched healthy donors. J. Proteome Res. 5 (2006) 2599-2610
36. Jokiranta T.S., Jaakola V.P., Lehtinen M.J., Parepalo M., Meri S., and Goldman A. Structure of complement factor H carboxyl-terminus reveals molecular basis of atypical haemolytic uremic syndrome. EMBO J. 25 (2006) 1784-1794
37. Fernando A.N., Furtado P.B., Clark S.J., Gilbert H.E., Day A.J., Sim R.B., and Perkins S.J. Associative and structural properties of the region of complement factor H encompassing the Tyr402His disease-related polymorphism and its interactions with heparin. J. Mol. Biol. 368 (2007) 564-581
38. Okemefuna A.I., Gilbert H.E., Griggs K.M., Ormsby R.J., Gordon D.L., and Perkins S.J. The regulatory SCR-1/5 and cell-surface-binding SCR-16/20 fragments of factor H reveal partially folded-back solution structures and different self-associative properties. J. Mol. Biol. 375 (2008) 80-101
39. AREDS Research Group. The effect of five-year zinc supplementation on serum zinc, serum cholesterol and hematocrit in persons randomly assigned to treatment group in the Age-Related Eye Disease Study. J. Nutr. 132 (2002) 687-702
40. AREDS Research Group. A randomized, placebo-controlled, clinical trial of high-dose supplementation with vitamins C and E, beta carotene, and zinc for age-related macular degeneration and vision loss. Arch. Ophthalmol. 119 (2001) 1417-1436
41. e in the central nervous system during simple anesthetization, ischemia and reperfusion. Exp. Neurol. 198 (2006) 285-293
42. Ugarte M., and Osborne N.N. Zinc in the retina. Prog. Neurobiol. 64 (2001) 219-249
43. Newsome D.A., Oliver P.D., Deupree D.M., Miceli M.V., and Diamond J.G. Zinc uptake by primate retinal pigment epithelium and choroid. Curr. Eye Res. 11 (1992) 213-217
44. Lengyel I., and Peto T. Cure or cause: the opposing roles for zinc in age-related macular degeneration. Expert Rev. Ophthalmol. 3 (2008) 1-4
45. Auld D.S. Zinc coordination sphere in biochemical zinc sites. BioMetals 14 (2001) 271-313
46. Flinn J.M., Cano K., Gideons E., Koscho J., Ablett J., Jones B.F., et al. Trace metal distribution and concentration in sub-RPE deposits and Bruch's membrane in post-mortem human tissues. Invest. Ophthalmol. Visual Sci. 49 (2008) E-1756 Abstract
47. Scholl H.P.N., Issa P.C., Walier M., Janzer S., Pollok-Kopp B., Borncke F., et al. Systematic complement activation in age-related macular degeneration. PLoS ONE 3 (2008) e2593
48. Lengyel I., Tufail A., Hosaini H.A., Luthert P., Bird A.C., and Jeffery G. Association of drusen deposition with choroidal intercapillary pillars in the aging human eye. Invest. Ophthalmol. Visual Sci. 45 (2004) 2886-2892
49. Jager R.D., Mieler W.F., and Miller J.W. Age-related macular degeneration. New Engl. J. Med. 358 (2008) 2606-2617
50. Wills N.K., Sadagopa Ramanujum V.M., Kalariya N., Lewis J.R., and van Kuijk F.J.G.M. Copper and zinc distribution in the human retina: relationship to cadmium accumulation, age and gender. Exp. Eye Res. 87 (2008) 80-88
51. Coffey P.J., Gias C., McDermott C.J., Lundh P., Pickering M.C., Sethi C., et al. Complement factor H deficiency in aged mice causes retinal abnormalities and visual dysfunction. Proc. Natl Acad. Sci. USA 104 (2007) 16651-16656
52. Ritchie C.W., Bush A.I., Mackinnon A., Macfarlane S., Mastwyk M., MacGregor L., et al. Metal-protein attenuation with iodochlorhydroxyquin (clioquinol) targeting Aβ amyloid deposition and toxicity in Alzheimer disease. Arch. Neurol. 60 (2003) 1685-1691
53. Sim R.B., Day A.J., Moffatt B.E., and Fontaine M. Complement factor I and cofactors in control of complement system convertase enzymes. Methods Enzymol. 223 (1993) 13-35
54. Dodds A.W. Small-scale preparation of complement components C3 and C4. Methods Enzymol. 223 (1993) 46-61
55. Ullman C.G., Chamberlain D., Emery V.C., Haris P.I., Sim R.B., and Perkins S.J. Human complement factor I: its expression by insect cells and its biochemical and structural characterisation. Mol. Immunol. 35 (1998) 503-512
56. Perkins S.J., and Sim R.B. Molecular modelling of human complement component C3 and its fragments by solution scattering. Eur. J. Biochem. 157 (1986) 155-168